<DOC>
	<DOC>NCT00130871</DOC>
	<brief_summary>The study evaluates the efficacy of intravenous levosimendan treatment started during a coronary artery bypass operation to wean patients from a heart lung machine.</brief_summary>
	<brief_title>Levosimendan Pretreatment for Weaning Patients From Cardio-Pulmonary Bypass</brief_title>
	<detailed_description>Levosimendan or placebo infusion is started at the time of induction of anesthesia.</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Simendan</mesh_term>
	<criteria>Three vessel coronary artery disease. Indication for onpump coronary artery bypass surgery. Ejection fraction below 50% Indication for any cardiac valve surgery Previous coronary artery bypass surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>levosimendan</keyword>
	<keyword>weaning</keyword>
	<keyword>cardio-pulmonary bypass</keyword>
</DOC>